It has a long history as a fuel for heat and light, and more recently as a fuel for internal combustion engines. See also
References
Further reading
External links

Alcohol (Ethanol) at The Periodic Table of Videos (University of Nottingham)
International Labour Organization ethanol safety information
National Pollutant Inventory – Ethanol Fact Sheet
CDC – NIOSH Pocket Guide to Chemical Hazards – Ethyl Alcohol
National Institute of Standards and Technology chemical data on ethanol
Chicago Board of Trade news and market data on ethanol futures
Calculation of vapor pressure, liquid density, dynamic liquid viscosity, surface tension of ethanol
Ethanol History A look into the history of ethanol
ChemSub Online: Ethyl alcohol
Industrial ethanol production process flow diagram using ethylene and sulphuric acid
In individuals with moderate to severe disease who may not tolerate glucocorticoids, lower dose prednisone monotherapy or combination with azathioprine is a reasonable alternative. Budesonide has been shown to be more effective in inducing remission than prednisone, but evidence is scarce and more data is needed before it can be routinely recommended. Those with autoimmune hepatitis who do not respond to glucocorticoids and azathioprine may be given other immunosuppressives like mycophenolate, ciclosporin, tacrolimus, or methotrexate.Liver cirrhosis can develop in about 7% to 40% of treated patients. People with the highest risk for progression to cirrhosis are those with incomplete response to treatment, treatment failure, and multiple relapses. Once cirrhosis develops, management of liver cirrhosis in autoimmune hepatitis is standard regardless of etiology. Liver transplantation is the standard of care in people presenting with fulminant liver failure or those with the progression of disease despite multiple lines of therapy. Prognosis
Without treatment, the ten-year survival rate for individuals with symptomatic autoimmune hepatitis is 50%. However, with treatment, the ten-year survival rate is above 90%. Despite the benefits of treatment, people with autoimmune hepatitis generally have a lower transplant-free survival than the general population. Outcomes with liver transplant are generally favorable with a five-year survival greater than 80 percent.Presentation and response to therapy may differ according to race. African Americans appear to present with a more aggressive disease that is associated with worse outcomes.There has been strong evidence that patients with autoimmune hepatitis can develop mental health disorders like schizophrenia and bipolar disorder later in their life.